RKDAArcadia Biosciences, Inc. · Nasdaq Capital Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

2.18M
Reported Float
2.18M
Tradeable Now
(estimated float)
6.06M
Effective Supply
16.11M
Fully Diluted
Dilution risk7/10
CONFIDENCE: HIGH
HIGHAssessed Jul 9, 2026Trigger: EFFECT registration filingCRITICALNear-zero-strike pre-funded warrant overhangHIGHRecently effective large resale registration

Driven by supply mechanics, not fundamentals: 3,883,496 pre-funded warrants at $0.0001 (178% of the 2.18M float) are exercisable now and registered for resale — effectively issued stock that can flood the tape in 9.99%-capped tranches. Layered on top are 7.77M preferred investment options at $0.91 (Series A-1/A-2, ~26% above the $0.72 price — near-the-money, one small rally from becoming live supply) plus 1.67M Jan-2026 options at $2.325. A total resale shelf of 11.9M shares (5.5x float) is already effective. Tempered from EXTREME because there are NO variable-rate/floating conversion (death-spiral) mechanisms — all strikes are fixed and the largest option tranches are currently out-of-the-money.

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry. Adjusted based on SEC filing analysis.

Reported Float2.18M13.5%
Warrants13.79M85.6%
pre-funded3.88M shares at $0.0001
common3.88M shares at $0.91
common3.88M shares at $0.91
placement_agent272K shares at $1.2875
common1.62M shares at $2.325
placement_agent57K shares at $3.2188
common198K shares at $120
Options / RSUs177K1.1%
Stock Options177K shares
≈ Estimated Actual Float

Reported float + filing adjustments

2.18M

HIGH confidence

Pending Shares as % of Float641.4%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted16.11M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits (2)
  • 1-for-40·Mar 1, 2023~3 yr ago
  • 1-for-20·Jan 24, 2018~9 yr ago
Active mechanisms
  • 3.88M pre-funded warrants at $0.0001 exercisable now (registered for resale)
  • Series A-2 preferred investment options 3.88M at $0.91 exercisable now (registered, near-money)
  • Series A-1 preferred investment options 3.88M at $0.91 pending stockholder approval
  • January 2026 investment options 1.62M at $2.325 (registered, effective)
  • Effective S-3 resale registration covering 11.92M shares

Market Data

Price

$0.64

Market Cap

$1.40M

Outstanding

2.18M

Float

2.18M

Avg Volume

54.5K

Exchange: NASDAQ|Source: Insight Sentry